Claudia S. Toussaint - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Role
EVP, CPSO
Signature
/s/ Mike Nazario, by power of attorney for Claudia S. Toussaint
Issuer symbol
XYL
Transactions as of
01 Mar 2026
Net transactions value
+$1,354,677
Form type
4
Filing time
03 Mar 2026, 16:51:19 UTC
Previous filing
31 Oct 2025
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Toussaint Claudia S EVP, CPSO C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON /s/ Mike Nazario, by power of attorney for Claudia S. Toussaint 03 Mar 2026 0001421560

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Award $304,393 +2,360 +60% $128.98 6,299 01 Mar 2026 Direct F1
transaction XYL Common Stock Award $251,253 +1,948 +31% $128.98 8,247 01 Mar 2026 Direct F2
transaction XYL Common Stock Award $170,770 +1,324 +16% $128.98 9,571 01 Mar 2026 Direct F3
transaction XYL Common Stock Award $227,134 +1,761 +18% $128.98 11,332 01 Mar 2026 Direct F4
transaction XYL Common Stock Award $0 +1,989 +18% $0.000000 13,321 02 Mar 2026 Direct F5
transaction XYL Common Stock Tax liability $332,768 -2,580 -19% $128.98 10,741 02 Mar 2026 Direct F6
transaction XYL Common Stock Tax liability $102,797 -797 -7.4% $128.98 9,944 02 Mar 2026 Direct F7
transaction XYL Common Stock Tax liability $77,646 -602 -6.1% $128.98 9,342 02 Mar 2026 Direct F8
holding XYL Common Stock 31,250 01 Mar 2026 by Claudia S. Toussaint Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Non-Qualified Stock Options (Right to Buy) Award $914,339 +7,089 $128.98 7,089 02 Mar 2026 Common Stock 7,089 $128.98 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the acquisition of 2,360 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2 Reflects the acquisition of 1,948 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
F3 Reflects the acquisition of 1,324 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
F4 Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
F5 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
F6 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (336) and March 1, 2024 (266) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F9 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.